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BUILDING the
RESEARCH ENTERPRISE of 2028
This edition of Jefferson Research offers a tantalizing peek at the array
of work done at Thomas Jefferson University: from how mitochondria
communicate with nearby organelles, to the use of innovative
textiles to reduce a building’s energy consumption; from how “digital
readiness” can improve health equity, to space travel’s effects on the
immune system.
It also serves as a lens on the exciting path that the our university's
research community will pursue over the next five years, guided by
our new strategic plan for the Jefferson Research Enterprise. The
carefully calibrated plan draws on insights from faculty, students and
staff across the institution. It is rooted in the University’s overarching
tripartite objective: Before decade’s end, Jefferson will be recognized
as a national research university distinguished by programmatic
excellence, innovation and multidisciplinary, multi-sector
partnerships. We will be seen as the model for professions-focused
higher education. We will be a distinctive, robust global presence in
research and education.
Our research strategy builds on our nearly 200-year legacy of
pioneering achievements in education, scientific discovery and
technical invention. Excellence, innovation and collaboration are
woven through the four core elements of our strategic plan.
First, we will leverage the programmatic research themes we have
developed over the past decade to create or expand a select number
of centers of research excellence (CRE). Prioritized by their potential
for scientific and social impact, the CREs will address fields ranging
from Smart and Healthy Cities to Life Energetics to Small RNA
Discovery to Fashion and Textile Futures — and will include
continued expansion of research at our NCI-designated Sidney
Kimmel Cancer Center — Jefferson Health, the Vickie & Jack Farber
Institute for Neuroscience, and the Computational Medicine
Center, as well as launch of a Center for Vaccines and Pandemic
Preparedness and an Institute for Global Health Security.
At the same time, we will continue advancing the work of
individual scholars and small teams as they create and apply
knowledge across a broad range of subjects: from investment
banking practices, to the psychological roots of conspiracy theories;
from sustainable architecture to racism in news media; from
dissemination of Africa-based scholarship to the roots of creativity,
and to women as entrepreneurs. (You’ll find examples of this
exciting and impactful research in the pages of this magazine.)
Second, replicating the success of the Jefferson Institute for
Bioprocessing, we will launch a series of education-based initiatives
that have significant research and development components. Those
initiatives will leverage the rich potential — and Jefferson’s existing
strengths — in areas such as Heatlh Cybersecurity, Biocomputation
Human Factors Engineering and Design Thinking.

4
Thomas Jefferson University
Published by Jefferson Digital Commons, 2022

Third, we will continue growing our clinical research program
(which now has more than 1,300 active clinical trials), aiming
to increase patient participation by 50 percent. Toward that
goal, we will build programs to address the specific needs of
Jefferson’s communities through targeted trials addressing
clinical challenges such as stroke, cardiac disease and diabetes.
This initiative is just one facet of a cross-cutting commitment
to expand population science research across the University—
especially the kind of work that will enable us to understand and
counter the roots of health disparities.

The new relationships we create with our local communities
will be the cornerstone of the fourth core element of our
research plan: expanded partnerships and collaborations. We
will, for example, launch regional partnerships to access highend technologies; and catalyze national consortia to pursue
targeted, high-impact research challenges. Of course, we will
also expand the research programs undertaken by our seven
Jefferson global centers and Consortia and by investigator-driven
collaborative studies in 23 countries. With our partners, we
will continue to address challenges ranging from maternal and
infant death in India to road traffic injuries in Rwanda; and pursue
collaborations that open new horizons — such as our work with
investigators in Israel on biomedical projects to be undertaken
on the International Space Station, and our robotics and artificial
intelligence research in Japan.
Over the past decade, building on our predecessors’ achievements, we
have fortified the foundation of a truly extraordinary research
enterprise. That foundation includes a world-class faculty, stateof-the-art core facilities and an energetic culture of team science
and interdisciplinary exchange. We have established strong
seed- and bridge-funding mechanisms and garnered steadily
increasing external support: since 2017, our research revenue
from agencies, corporations and foundations has grown by more
than 64 percent. The dynamic expansion of our discovery and
scholarship is reflected in a quadrupling of our publications to
over 4,000 this past year.
In reading this magazine, I think you will see why we are so
proud of what we have accomplished, and so enthusiastic about
the future of Jefferson’s research enterprise. I firmly believe it
will be a future of both profound discovery and truly beneficial
impact for our community and our world. 

Mark L. Tykocinski, MD
Executive Vice President, Academic Affairs
Provost, Thomas Jefferson University
Anthony F. and Gertrude M. DePalma Dean
Sidney Kimmel Medical College

Programmatic Research

“Programmatic, basic and translational studies are the bedrock of scientific research at Jefferson, and
we are continuing to build on our areas of great strength. These include nationally recognized
programs in cancer mechanisms and immunotherapies, neurodevelopment and neurodegeneration,
infectious diseases and vaccines, fibrotic disease and RNA biology. We will launch other initiatives in
highly promising areas as well — and, working across disciplines and disease areas, we are committed
to having real impact in reducing disparities in care and addressing the nonbiological causes of
disease. To empower our investigators, we will continue making major investments in new research
technologies — capitalizing, for example, on recent acquisitions of flow cytometry and cryo-EM
systems, expanding our bioinformatics infrastructure, and making large-scale additions to the
laboratories and core facilities available to our investigators.” 
Steven B. McMahon, Ph.D.
Senior Associate Provost for Programmatic Science

Clinical Research
“Clinical research brings the leading edge of our knowledge and scientific creativity directly to patients
to improve medical care. Over the next five years, we will continue to empower our physicians and
other investigators to advance new and better ways to promote health and detect, diagnose and treat
disease. To that end, we will encourage substantially more faculty to engage in clinical research, in
several ways: first, by expanding the successful “Clinical Research Boot Camp” for new clinicianscientists; second, by offering more Emerging Medical Science awards, which provide protected time
for early career investigators; third, by increasing internal funding for pilot projects that translate
faculty research into real interventions. We will also build infrastructure, such as the Jefferson Health
Informatics Core, to help investigators organize and analyze electronic health records in ways that yield
population-level insights and point the way to community-focused clinical research initiatives.” 
David Whellan, MD, MHS
Senior Associate Provost for Clinical Research
James C. Wilson Professor of Medicine

Applied Research
“At Jefferson, the term ‘applied research’ has broad application. It ranges from studies of soft materials
and surface imaging to antitrust laws’ effect on foreign investment. It includes academic-corporate
partnerships where our industrial designers investigate and develop solutions for real people’s
challenges, and multidisciplinary projects with concrete impact—such as our initiative that bridges
political science, economics, management, and materials science to help develop a sustainable and
profitable hemp-based industry.
"In the next few years, we will expand our core capacities to do intellectually rigorous, impactful
applied research by providing more bridge and project-completion grants to faculty, expanding
dedicated research space on our East Falls campus, and increasing funding for graduate research and
technical staff. With those resources, we will grow an array of already strong programs in areas such
as business structure and supply chain modeling, product design and development, sustainability and
building systems, and textile and materials technology.” 
Ronald Kander, PhD
Associate Provost for Applied Research
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